• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤患者的感染:流行病学、病理生理学、危险因素、诊断与治疗

infection in oncology patients: epidemiology, pathophysiology, risk factors, diagnosis, and treatment.

作者信息

Abughanimeh Omar, Qasrawi Ayman, Kaddourah Osama, Al Momani Laith, Abu Ghanimeh Mouhanna

机构信息

a School of Medicine Internal Medicine , University of Missouri , Kansas City , USA.

b East Tennessee State University James H Quillen College of Medicine - Internal Medicine , USA.

出版信息

Hosp Pract (1995). 2018 Dec;46(5):266-277. doi: 10.1080/21548331.2018.1533673. Epub 2018 Oct 15.

DOI:10.1080/21548331.2018.1533673
PMID:30296190
Abstract

infection (CDI) is one of the most common healthcare-associated infections in the United States. Its incidence has been increasing in the recent years despite preventative measures. CDI increases annual expenses by 1.5 billion dollars. Cancer patients are at higher risk to acquire CDI, as explained by their frequent exposure to risk factors. CDI in cancer patients is associated with higher mortality rates and prolonged hospitalization. Furthermore, CDI affects the course of the disease by delaying treatments such as chemotherapy. Chemotherapeutics drugs are considered independent risk factors for CDI. This review discusses infection in cancer patients, including those who are receiving chemotherapy. Herein, we summarize recent data regarding the epidemiology, risk factors, including chemotherapy regimens, pathogenesis, diagnostic techniques and treatment options, including newer agents. : A literature search was performed using the PubMed and Google Scholar databases. The MeSH terms utilized in different combinations were '', 'neoplasia/cancer/oncology', 'chemotherapy', 'diagnosis', and 'treatment', in addition to looking up each treatment option individually to generate a comprehensive search. The articles were initially screened by title alone, followed by screening through abstracts. Full texts of pertinent articles (including letters to editors, case reports, case series, cohort studies, and clinical trials) were included in this review.

摘要

艰难梭菌感染(CDI)是美国最常见的医疗保健相关感染之一。尽管采取了预防措施,但其发病率近年来仍在上升。CDI使年度费用增加了15亿美元。癌症患者感染CDI的风险更高,这是由于他们频繁接触风险因素所致。癌症患者的CDI与更高的死亡率和更长的住院时间相关。此外,CDI通过延迟化疗等治疗影响疾病进程。化疗药物被认为是CDI的独立风险因素。本综述讨论了癌症患者的感染,包括正在接受化疗的患者。在此,我们总结了有关流行病学、风险因素(包括化疗方案)、发病机制、诊断技术和治疗选择(包括新型药物)的最新数据。:使用PubMed和谷歌学术数据库进行了文献检索。除了单独查找每个治疗选项以进行全面搜索外,还以不同组合使用了医学主题词“艰难梭菌感染”、“肿瘤/癌症/肿瘤学”、“化疗”、“诊断”和“治疗”。文章最初仅通过标题进行筛选,随后通过摘要进行筛选。本综述纳入了相关文章的全文(包括给编辑的信、病例报告、病例系列、队列研究和临床试验)。

相似文献

1
infection in oncology patients: epidemiology, pathophysiology, risk factors, diagnosis, and treatment.肿瘤患者的感染:流行病学、病理生理学、危险因素、诊断与治疗
Hosp Pract (1995). 2018 Dec;46(5):266-277. doi: 10.1080/21548331.2018.1533673. Epub 2018 Oct 15.
2
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.癌症患者和造血干细胞移植受者中的艰难梭菌感染。
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1113-9. doi: 10.1586/eri.10.95.
3
Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.心力衰竭合并常见细菌感染的住院患者:全国范围内艰难梭菌合并感染率及住院死亡率分析
J Card Fail. 2016 Nov;22(11):891-900. doi: 10.1016/j.cardfail.2016.06.005. Epub 2016 Jun 16.
4
Clostridium difficile. A review on an emerging infection.艰难梭菌。关于一种新发感染的综述。
Clin Ter. 2019 Jan-Feb;170(1):e41-e47. doi: 10.7417/CT.2019.2106.
5
Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.复发性艰难梭菌感染与癌症患者的治疗失败和病程延长有关。
Eur J Gastroenterol Hepatol. 2019 Jan;31(1):128-134. doi: 10.1097/MEG.0000000000001288.
6
How to: Surveillance of Clostridium difficile infections.方法:艰难梭菌感染的监测。
Clin Microbiol Infect. 2018 May;24(5):469-475. doi: 10.1016/j.cmi.2017.12.008. Epub 2017 Dec 20.
7
Clostridium difficile Infection in travelers--a neglected pathogen?旅行者艰难梭菌感染——被忽视的病原体?
J Travel Med. 2013 Jan-Feb;20(1):37-43. doi: 10.1111/j.1708-8305.2012.00676.x. Epub 2012 Dec 4.
8
Analysis of risk factors and outcomes of Clostridium difficile infection.
Folia Med Cracov. 2018;58(4):105-116.
9
Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.连续质子泵抑制剂治疗与复发性艰难梭菌感染的相关风险。
JAMA Intern Med. 2015 May;175(5):784-91. doi: 10.1001/jamainternmed.2015.42.
10
Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.中国北京住院癌症患者的艰难梭菌感染是由接受癌症化疗促成的。
Anaerobe. 2013 Dec;24:82-4. doi: 10.1016/j.anaerobe.2013.05.004. Epub 2013 Jun 14.

引用本文的文献

1
Bezlotoxumab for the prevention of recurrent infection for patients with cancer.贝佐妥单抗用于预防癌症患者反复感染。
Ann Gastroenterol. 2025 Sep-Oct;38(5):519-525. doi: 10.20524/aog.2025.0994. Epub 2025 Aug 14.
2
Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer: critical perspective in management.结直肠癌患者艰难梭菌感染的危险因素及结局:管理中的关键视角
Gut Pathog. 2025 Jun 14;17(1):44. doi: 10.1186/s13099-025-00717-0.
3
Impact of colon cancer on outcomes in hospitalized patients with infection: a national inpatient analysis.
结肠癌对感染住院患者预后的影响:一项全国性住院患者分析
Proc (Bayl Univ Med Cent). 2024 May 15;37(4):544-550. doi: 10.1080/08998280.2024.2352817. eCollection 2024.
4
The complete catalog of antimicrobial resistance secondary active transporters in : evolution and drug resistance perspective.从进化和耐药性角度看:抗菌药物耐药性次级主动转运蛋白的完整目录
Comput Struct Biotechnol J. 2024 May 21;23:2358-2374. doi: 10.1016/j.csbj.2024.05.027. eCollection 2024 Dec.
5
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study.艰难梭菌复发在癌症患者和非癌症患者中的差异:一项基于瑞典人群的队列研究。
Infection. 2024 Apr;52(2):649-660. doi: 10.1007/s15010-024-02193-1. Epub 2024 Feb 26.
6
Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications.儿科肿瘤患者中艰难梭菌感染的患病率增加:感染和并发症的危险因素。
Pediatr Infect Dis J. 2024 Feb 1;43(2):136-141. doi: 10.1097/INF.0000000000004178. Epub 2023 Dec 21.
7
Infections among Pediatric Patients Hospitalized at an Oncology Department of a Tertiary Hospital in Poland.波兰一家三级医院肿瘤科住院儿科患者的感染情况。
Medicina (Kaunas). 2023 Jul 25;59(8):1363. doi: 10.3390/medicina59081363.
8
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.在一家儿科癌症医院进行的艰难梭菌症状感染的病例对照研究。
Rev Paul Pediatr. 2023 Mar 13;41:e2022117. doi: 10.1590/1984-0462/2023/41/2022117. eCollection 2023.
9
Clostridium difficile Infection Is Associated With Decreased Prostate Cancer Risk: A Retrospective Cohort Study.艰难梭菌感染与前列腺癌风险降低相关:一项回顾性队列研究。
Cureus. 2023 Jan 30;15(1):e34398. doi: 10.7759/cureus.34398. eCollection 2023 Jan.
10
Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.癌症相关微生物群:从疾病致病机制到以微生物群为中心的抗癌方法
Biology (Basel). 2022 May 16;11(5):757. doi: 10.3390/biology11050757.